SCHEMBL2880398

SCHEMBL2880398

CC(C)Oc1cccc(Oc2nc(C(=O)O)co2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 6/20 0.46
KLKB1 P03952 1/20 0.45
RXRA P19793 1/20 0.44
RXRB P28702 1/20 0.44
BCL2 P10415 2/20 0.41
MDM2 Q00987 2/20 0.41
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 3/20 0.40
NSD2 O96028 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
F2 P00734 1/20 0.39
F10 P00742 1/20 0.39
KMT2A Q03164 2/20 0.39
GCK P35557 2/20 0.38
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38
ACMSD Q8TDX5 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
KAT6A Q92794 1/20 0.38
FFAR4 Q5NUL3 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1660196 0.86 PTGS1 (0.45) KLKB1RXRARXRBALDH1A1KDM4E
SCHEMBL2873881 0.81 P2RX3 (0.42) KLKB1RXRARXRB
SCHEMBL2638065 0.81 KLKB1 (0.42) MCL1KLKB1ALDH1A1KDM4EF2
SCHEMBL2866332 0.81 MCL1 (0.45) MCL1KLKB1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL2878994 0.81 PTGS1 (0.40) MCL1KLKB1ALDH1A1KMT2AMEN1
SCHEMBL1660164 0.81 KLKB1 (0.44) KLKB1BCL2ALDH1A1KDM4ESMN1; SMN2
SCHEMBL1661912 0.81 KLKB1 (0.42) KLKB1RXRARXRB
SCHEMBL2638952 0.78 MAPT (0.50) ALDH1A1KDM4E
SCHEMBL2873902 0.78 HAO1 (0.50) KLKB1
SCHEMBL2866370 0.78 KLKB1 (0.40) KLKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2307394-B1 SULPHONAMIDES AS VANILLOID RECEPTOR ANTAGONIST AMOREPACIFIC CORP (KR) 2012-09-26 EP disclosed
WO-2010002209-A2 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2010-01-07 WO disclosed